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This paper describes the cloning of the genes coding for each
component of the complex of toluene/o-xylene monooxy-
genase from Pseudomonas stutzeri OX1, their expression,
puriﬁcation and characterization. Moreover, the reconsti-
tution of the active complex from the recombinant subunits
has been obtained, and the functional role of each compo-
nent in the electron transfer from the electron donor to
molecular oxygen has been determined.
The coexpression of subunits B, E and A leads to the
formation of a subcomplex, named H, with a quaternary
structure (BEA)2, endowed with hydroxylase activity.
Tomo F component is an NADH oxidoreductase. The
puriﬁed enzyme contains about 1 mol of FAD, 2 mol of
iron, and 2 mol of acid labile sulﬁde per mol of protein, as
expected for the presence of one [2Fe)2S] cluster, and
exhibits a typical ﬂavodoxin absorption spectrum.
Interestingly, the sequence of the protein does not cor-
respond to that previously predicted on the basis of DNA
sequence.We have shown that this depends onminor errors
in the gene sequence that we have corrected.
C component is a Rieske-type ferredoxin, whose iron and
acid labile sulﬁde content is in agreementwith thepresenceof
one [2Fe)2S] cluster. The cluster is very sensitive to oxygen
damage.
Mixtures of the subcomplex H and of the subunits F, C
and D are able to oxidize p-cresol into 4-methylcathecol,
thus demonstrating the full functionality of the recombinant
subunits as puriﬁed.
Finally, experimental evidence is reported which strongly
support a model for the electron transfer. Subunit F is the
ﬁrst member of an electron transport chain which transfers
electrons from NADH to C, which tunnels them to H sub-
complex, and eventually to molecular oxygen.
Keywords: monooxygenase; protein expression; electron
transfer; bioremediation; recombinant.
Several strains from Pseudomonas genus grow on aromatic
compounds due to enzymatic systems able to activate
aromatic rings by mono- and di-hydroxylations and to
operate ortho ormeta-cleavage pathway [1,2] which leads to
citric acid cycle intermediates.
Toluene/o-xylene-monooxygenase (Tomo) from Pseudo-
monas stutzeri OX1 [3,4] is endowed with a broad spectrum
of substrate speciﬁcity [3], and the ability to hydroxylate
more than a single position of the aromatic ring in two
consecutive monooxygenation reactions [3]. Thus Tomo is
able to oxidize o-, m- and p-xylene, 2,3- and 3,4-dimethyl-
phenol, toluene, cresols, benzene, naphthalene, ethylben-
zene, styrene [3], trichloroethylene, 1,1-dichloroethylene,
chloroform [5] and tetrachloroethylene [6]. This makes the
complex unique with respect to other known monooxygen-
ases, such as toluene/benzene-2-monooxygenase from the
Pseudomonas sp. strain JS150 [7], toluene-3-monooxygenase
from Pseudomonas pickettii PKO1 [8], toluene-4-mono-
oxygenase (T4MO) from Pseudomonas mendocinaKR1 [9],
and toluene-2-monooxygenase (T2MO) from Burkholderia
cepacia G4 [10], and potentially useful for its use in
bioremediation strategies [5,6,11] and/or the synthesis of
commercially valuable compounds [12].
The genes coding for toluene/o-xylene monooxygenase
have been cloned in pGEM 3Z vector (pBZ1260) [3]. The
nucleotide sequence revealed six ORFs, named tou A, B,
C, D, E and F (tou, for toluene/o-xylene utilization), which
showed relevant similarities to the subunits of several
enzymatic complexes involved in the oxygenation of
aromatic compounds [4]. On the basis of homology
studies of the coding gene sequence [4] it has been
hypothesized that the gene products of the cluster form an
electron transfer complex in which Tomo F, an NADH-
oxidoreductase, is the ﬁrst member of the electron
transport chain. Tomo F is able to transfer electrons
from NADH to Tomo C, which is a Rieske-type
ferredoxin that tunnels electrons to the terminal oxyge-
nase, the Tomo H subcomplex composed by the tuoA,
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touB and touE gene products. Finally, another member of
the complex is subunit Tomo D, for which a regulatory
function has been suggested [4,13].
The present study reports the cloning, expression and
puriﬁcation of the individual components of Tomo in
Escherichia coli, and their reconstitution into a functional
complex. Subunits Tomo A, B, C, D and E were expressed
in soluble form, while subunit Tomo F was expressed as an
insoluble product, renaturated in vitro, and puriﬁed. To our
knowledge, this is the ﬁrst example of a ﬂavodoxin refolded
from inclusion bodies.
M A T E R I A L S A N D M E T H O D S
Materials
Bacterial cultures, plasmid puriﬁcations and transforma-
tions were performed according to Sambrook [14]. Double
stranded DNA was sequenced with the dideoxy method of
Sanger [15], carried out with the Sequenase version II
Sequencing Kit and labeled nucleotides from Amersham.
pET22b(+) expression vector and E. coli strain BL21DE3
were from Novagen, whereas E. coli strain JM101 was
purchased from Boehringer. The thermostable recombi-
nant DNA polymerase used for PCR ampliﬁcation was
PLATINUM Pfx from Life Technologies, and deoxynucle-
otide triphosphates were purchased from Perkin-Elmer
Cetus. The Wizard PCR Preps DNA Puriﬁcation System
for elution of DNA fragments from agarose gel was
obtained from Promega. Enzymes and other reagents for
DNA manipulation were from New England Biolabs. The
oligonucleotides were synthesized at the Stazione Zoologica
A. Dohrn (Naples, Italy). Poly(vinylidene diﬂuoride)
(PVDF) membranes were from Perkin Elmer Cetus.
Protease inhibitor cocktail EDTA-free tablets were pur-
chased from Boehringer. Superose 12 PC 3.2/30, Q-Seph-
arose Fast Flow, Sephacryl S300 High Resolution and
Sephadex G75 Superﬁne, and disposable PD10 desalting
columns were from Pharmacia. DEAE-Cellulose DE52 was
fromWhatman, CNBr was from Pierce, cytochrome c from
horse heart, trypsin and bovine insulin from Sigma. All
other chemicals were from Sigma. Tomo D subunit was
expressed and puriﬁed as described [13]. The expression and
puriﬁcation of catechol 2,3-dioxygenase from P. stutzeri
OX1 will be described in a different paper (Viggiani,
manuscript in preparation).
Construction of expression vectors
The individualgenes touA,B,C,D,EandFwereobtainedby
PCR ampliﬁcation of the DNA coding for the complex
(GenBank,accessionnumberAJ005663)cloned intoplasmid
pGEM 3Z (pBZ1260) [3], kindly supplied by P. Barbieri
(Dipartimento di Biologia Strutturale e Funzionale, Univer-
sita` dell’Insubria, Varese, Italy). Synthetic oligonucleotide
primersweredesigned to insert theappropriate endonuclease
restriction sites at the5¢and3¢ endsof eachgene toallow their
polar cloning into pET22b(+) expression vector.
The DNA fragments coding for Tomo C and Tomo B
from the PCR ampliﬁcations were isolated by agarose
gel electrophoresis, eluted and digested with NdeI and
HindIII restriction endonucleases. The digestion products
were puriﬁed by electrophoresis, ligated with pET22b(+)
previously cut with the same enzymes, and used to
transform JM101 competent cells. The resulting recombin-
ant plasmids, named pET22b(+)/touC and pET22b(+)/
touB, were veriﬁed by DNA sequencing.
pET22b(+)/touBEA plasmid coding for the three sub-
units B, E and A was obtained by inserting touA and touE
genes into plasmid pET22b(+)/touB. This vector was ﬁrst
subjected to oligonucleotide mediated site-directed muta-
genesis according to Kunkel [16] to remove anXhoI internal
restriction site and to allow cloning of touE and touA genes
at the 3¢ end of the touB gene. For this purpose, the touE
sequence was subjected to PCRmutagenesis to insert aNotI
site at its 5¢ end and an EcoRI site followed by an XhoI site
at its 3¢ end. The mutagenized DNA fragment was isolated
by agarose gel electrophoresis, eluted and digestedwithNotI
and XhoI restriction endonucleases. The digestion product
was puriﬁed by electrophoresis, ligated with mutagenized
pET22b(+)/touB previously cut with NotI and XhoI, and
used to transform JM101 competent cells. The resulting
plasmid was then cut with EcoRI andXhoI and ligated with
touA, previously mutagenized by a PCR procedure to insert
an EcoRI site at its 5¢ end and a XhoI site at its 3¢ end, and
digested with the same enzymes. The ﬁnal product was
named pET22b(+)/touBEA.
When the DNA coding for Tomo F cloned into plasmid
pGEM 3Z (pBZ1006) [4] was sequenced (GenBank acces-
sion number AJ438269), we did not ﬁnd an A at position
6987, in accordance with the previously published sequence
(GenBank accession number AJ005663). This difference
generates a frame shift in our sequence which eliminates the
stop codon formerly present at nucleotide 7042 (nucleotide
numbering is given with reference to the sequence present in
the GenBank at accession number AJ005663), and locates a
new stop codon at nucleotide 7070.Moreover, at nucleotide
6851 was found to be a G instead of a C. The DNA coding
for Tomo F cloned into plasmid pGEM 3Z (pBZ1006) was
subjected to site-directed mutagenesis by PCR using two
speciﬁc synthetic oligonucleotides to insert at the 5¢ and 3¢
ends the appropriate endonuclease restriction sites (EcoRI
and NdeI at the 5¢, and HindIII at the 3¢) to allow cloning
into pUC118 and pET22b(+).
The resulting fragment was puriﬁed by agarose gel
electrophoresis, digested with EcoRI and HindIII, cloned
into pUC118 previously cut with the same enzymes, and
used to transform JM101 competent cells. This recombinant
plasmid was then subjected to a second round of site-
directed mutagenesis according to Kunkel [16], to remove
an internalNdeI restriction site. This was done to allow touF
cloning into the NdeI site of the expression vector
pET22b(+). The coding sequence was then removed from
pUC118 using NdeI and HindIII and subcloned in
pET22b(+) digested with the same enzymes, and puriﬁed.
The sequence of the resulting plasmid, named pET22b(+)/
touF, was veriﬁed by DNA sequencing.
Expression of recombinant plasmids
Plasmids pET22b(+)/touBEA, /touC and/touF, were
expressed using E. coli BL21DE3 cells.
All recombinant strains were routinely grown in LB
medium [14] supplemented with 50 lgÆmL)1 ampicillin.
Fresh BL21DE3 transformed cells were inoculated
into 10 mL of LB/ampicillin medium, at 37 C, up to
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D600 ¼ 0.7. These cultures were used to inoculate 1 L of LB
supplemented with 50 lgÆmL)1 ampicillin, and grown at
37 C until D600 ranged from 0.7 to 0.8.
Expression of recombinant proteins was induced by
adding isopropyl thio-b-D-galactoside at a ﬁnal concen-
tration of 25 lM for pET22b(+)/touBEA, 0.4 mM for
pET22b(+)/touC and 0.1 mM for pET22b(+)/touF. For
plasmids pET22b(+)/touBEA and /touC, at the time of
induction Fe(NH4)2(SO4)2 in H2SO4 was added at a ﬁnal
concentration of 100 lM. Growth continued for 3 h at
37 C in the case of pET22b(+)/touC, and at 25 C in
the case of pET22b(+)/touBEA and /touF. The cells
were harvested, washed with buffer A (25 mM Mops,
pH 6.9, containing 10% (v/v) ethanol, 5% (v/v) glycerol,
0.08 M NaCl and 2 mM dithiothreitol), collected by
centrifugation and the cell paste stored at )80 C until
needed.
An SDS/PAGE analysis of an aliquot of induced and
noninduced cells, after sonication and separation of the
soluble and insoluble fractions, revealed (data not shown)
that based on the expected molecular size of the polypep-
tides, all the proteins of interest were present in the soluble
fraction of the induced cell in the case of the expression of
pET22b(+)/touBEA and /touC, whereas the product of the
expression of pET22b(+)/touF was accumulated in the
insoluble fraction, presumably as inclusion bodies.
The proteins were identiﬁed by N-terminal sequencing on
samples blotted directly on PVDF membranes from elec-
trophoresis gels. This conﬁrmed that all the proteins were
the mature products of the corresponding genes.
Typical yields, on the basis of a densitometric scanning of
the electrophoresis proﬁles obtained after cell lysis, were
approximately 20–30 mgÆL)1 for Tomo C, 300 mgÆL)1 for
Tomo F, and 100 mgÆL)1 for the expression products of
pET22b(+)/touBEA.
Preparation of the soluble fraction from transformed
cells
The paste from 1 L culture of BL21DE3 cells transformed
with pET22b(+)/touC and pET22b(+)/touBEA was sus-
pended in 40 mL of buffer A containing an EDTA-free
protease inhibitor cocktail. Cells were disrupted by sonica-
tion (10 · 1 min cycle, on ice). Cell debris was removed by
centrifugation at 18 000 g for 60 min at 4 C. The super-
natant was immediately fractionated as described below.
Purification of Tomo C
Unless otherwise stated all chromatographic steps were
performed at 4 C. Buffers were made anaerobic by
repeated cycles of ﬂushing with nitrogen. Column opera-
tions were not strictly anoxic.
The soluble fraction from a 2-L culture of cells expressing
plasmid pET22b(+)/touC was loaded onto a Q-Sepharose
Fast Flow column (1 · 18 cm) equilibrated in buffer A at a
ﬂow rate of 10 mLÆh)1, and the column was further washed
with 50 mL of the same buffer. Proteins were eluted using a
300-mL linear salt gradient from 0.15 to 0.4 M NaCl in
buffer A, at a ﬂow rate of 10 mLÆh)1. Fractions eluting at
about 0.35 M NaCl were found to contain Tomo C, as
evidenced by UV/VIS absorption at 280 and 460 nm, SDS/
PAGE analysis, and N-terminal sequencing of the electro-
phoresis band electroblotted onto PVDF membranes [17]
(data not shown). Fractions eluting at 0.35 M NaCl were
pooled, concentrated by ultraﬁltration on YM3 mem-
branes, and loaded onto a Sephadex G75 Superﬁne column
(2.5 · 50 cm) equilibrated in buffer A containing 0.3 M
NaCl, at a ﬂow rate of 12 mLÆh)1. The ferredoxin peak
was concentrated by ultraﬁltration on YM3 membranes,
diluted threefold with buffer A, loaded again onto the
Q-Sepharose Fast Flow column, and eluted using the same
procedure described above. Fractions containing electro-
phoretically pure Tomo Cwere pooled, purged with N2 and
stored at )80 C. A molar extinction coefﬁcient at 458 nm
was determined among several preparations, and found to
be 6870 ± 130 M)1Æcm)1. This value is in good agreement
with those reported for other Rieske-type ferredoxins
[18,19]. Final yield was about 4 mg of protein from a 2-L
culture. Figure 1 shows an SDS/PAGE analysis of puriﬁed
Tomo C.
Tomo C preparations can be stored under a nitrogen
barrier at)80 Cat least for 8 months without any damage,
whereas storage at +4 or )20 C leads to the loss of their
spectral properties in few days.
Purification of the expression products of pET22b(+)/
touBEA
The soluble fraction from a 1-L culture of cells expres-
sing plasmid pET22b(+)/touBEA was loaded onto a
Q-Sepharose Fast Flow column (1 · 18 cm) equilibrated
in buffer A at a ﬂow rate of 10 mLÆh)1. The column was
washed further with 50 mL of the same buffer. Elution
was performed using a 300-mL linear salt gradient from
0.08–0.35 M NaCl in buffer A, at a ﬂow rate of
10 mLÆh)1. An SDS gel electrophoresis of the fractions
Fig. 1. SDS/PAGE analysis of Tomo puriﬁed subunits. Lanes 1 and 6,
molecular mass standards (b-galactosidase, 116.0 kDa, BSA,
66.2 kDa, ovalbumin, 45.0 kDa, lactate dehydrogenase, 35.0 kDa,
restriction endonuclease Bsp981, 25.0 kDa, b-lactoglobulin, 18.4 kDa,
lysozyme, 14.4 kDa). Lane 2, Tomo H (7 lg); lane 3 Tomo D (5 lg);
lane 4 Tomo C (5 lg); Lane 5, Tomo F (6 lg).
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eluted from the column indicated that fractions eluting at
0.3 M NaCl contained three polypeptides with an appar-
ent molecular mass of about 10, 38 and 57 kDa, the
expected molecular size of recombinant subunits B, E and
A, respectively. The identity of the proteins was further
checked by N-terminal sequencing of the electrophoresis
bands electroblotted onto PVDF membranes [17], by
their comparison with the sequences expected from the
translation of the coding genes. Relevant fractions were
pooled and concentrated by ultraﬁltration on YM30
membrane, then loaded onto a Sephacryl S300 High
Resolution column (2.5 · 50 cm) equilibrated in buffer A
containing 0.3 M NaCl, at a ﬂow rate of 6 mLÆh)1. Also
on this chromatographic matrix the three proteins
coeluted in a single peak containing Tomo B, E and A
polypeptides. Fractions were pooled, concentrated by
ultraﬁltration on YM30, and stored under nitrogen at
)80 C. The ﬁnal yield was about 20 mg of proteins per
litre of culture. The SDS/PAGE analysis of the complex
is shown in Fig. 1.
In vitro renaturation and purification of recombinant
Tomo F
To isolate inclusion bodies, cells from 1 L of culture were
suspended in 20 mL of 50 mM Tris/acetate, pH 8.4, and
sonicated (10 · 1 min cycle, on ice). The suspension was
then centrifuged at 18 000 g for 30 min at 4 C. In order
to remove membrane proteins, the cell pellet was washed
twice in 0.1 M Tris/acetate, pH 8.4, containing 4% (v/v)
Triton X-100 and 2 M urea, followed by repeated washes
in water, to eliminate traces of Triton and urea. Clean
inclusion bodies were then stored at )20 C as dry pellet
until use.
For in vitro renaturation of Tomo F, 10 mg of inclusion
bodies were dissolved at a ﬁnal concentration of
2 mgÆmL)1 in 0.1 M Tris/HCl, pH 8.4, containing 6 M
guanidine/HCl and 20 mM dithiothreitol, purged with O2-
free nitrogen and incubated for 3 h at 37 C. The sample
was then diluted 20-fold in 100 mL (ﬁnal volume) of a
refolding buffer containing 0.1 M Tris/HCl pH 7.0, 0.5 M
L-arginine, 50 lM FAD, 10 lM ferrous ammonium sulfate,
10 lM sodium sulﬁde, 2 mM dithiothreitol and 0.3 M
guanidine/HCl, at a ﬁnal protein concentration of
0.1 mgÆmL)1. After 1 h at room temperature, the mixture
was extensively dialyzed at 4 C against 50 mM Tris/HCl
pH 7.0, containing 5% (v/v) glycerol and 1 mM dithio-
threitol. The sample was then concentrated by ultraﬁltra-
tion on a YM30 membrane. Any insoluble material was
removed by centrifugation, and the supernatant was
then loaded onto a DEAE-Cellulose DE52 column
(0.5 · 10 cm) equilibrated in buffer A (25 mM Mops,
pH 6.9, containing 10% (v/v) ethanol, and 5% (v/v)
glycerol). The column was washed at a ﬂow rate of
10 mLÆh)1 with 20 mL of buffer A, and elution was
carried out stepwise with 20 mL of buffer A containing
0.1, 0.3 and 0.8 M NaCl, respectively. The fractions eluted
at 0.1 M NaCl contained Tomo F, as shown by SDS/
PAGE analysis (data not shown). They were pooled and
loaded onto a PD-10 gel ﬁltration column (1.6 · 5 cm)
equilibrated in 50 mM Tris/HCl, pH 7.0, containing 5%
(v/v) glycerol and 0.25 M NaCl, at a ﬂow rate of
2 mLÆmin)1. This last puriﬁcation step was necessary to
remove unincorporated FAD or any other small mole-
cules such as iron and sulfur before protein characteriza-
tion. The protein peak was purged with N2 and stored at
)80 C. Typical yields were 3–4 mg of Tomo F starting
from 10 mg of inclusion bodies. The SDS/PAGE analysis
of puriﬁed Tomo F is shown in Fig. 1.
A molar extinction coefﬁcient at 454 nm was determined
among several preparations, and found to be 48 100 ±
500 M)1Æcm)1.
Expression and preparation of recombinant apo-Tomo F
Expression and preparation of recombinant apo-Tomo F,
devoid of the [2Fe)2S] center, was obtained using the same
procedures described for recombinant Tomo F except for
the presence of 5 mM EDTA in all the steps of the
renaturation and puriﬁcation procedures to chelate iron and
prevent cluster formation.
Enzymatic assays of Tomo F reductase activity
NADH acceptor reductase activity of Tomo F was assayed
spectrophometrically using Tomo C as electron acceptor.
Assays were performed at 25 C by adding Tomo F (0.02–
8 lg) to 0.4 mL of a solution containing 25 mM Mops,
pH 6.9, 5% (v/v) glycerol, 10% (v/v) ethanol, 0.1 M NaCl,
60 lM NADH (or NADPH) and 20 lM Tomo C. Activity
was measured by recording the decrease in absorbance at
458 nm, using a De value of 3095 ± 105 M)1Æcm)1, the
difference between the extinction coefﬁcient of oxidized and
reduced Tomo C, one unit of activity being the lmoles of
reduced Tomo C formed per min at 25 C.
Multiple turnover assays for the reconstituted Tomo
complex
All assays were performed at 25 C in 0.1 M Tris/HCl,
pH 7.5. Tomo activity was assayed by determining the
4-methylcatechol (4-MC) produced by oxidation of p-cresol.
4-MC amount was measured in a coupled assay with
recombinant catechol 2,3-dioxygenase fromP. stutzeriOX1
[20] (Viggiani, manuscript in preparation), which cleaves the
4-MC ring and produces 2-hydroxymuconic semialdehyde.
This can be monitored at 410 nm (e ¼ 12 620 M)1Æcm )1).
The assaymixture contained, in a ﬁnal volume of 400 lL,
0.1 M Tris/HCl, pH 7.5, 1 mM NADH, 1 mM p-cresol,
saturating amounts of catechol 2,3-dioxygenase and the
four Tomo components. Component concentrations were
0.15 lM Tomo H, 0–1.2 lM Tomo F, 0–3 lM Tomo C and
0–3 lM Tomo D.
Assay mixtures were prepared with all components,
except for subunit Tomo F, and the reaction was initiated
by the addition of this latter recombinant subunit. The
absorbance increase at 410 nmwas then followed for 5 min.
Speciﬁc activity was expressed as nanomoles of p-cresol
converted per min per mg of complex at 25 C.
It should be added that controls were run to check the
presence of saturating amounts of NADH over the reaction
time. This was done by running duplicate assays and
monitoring the absorbance at 340 nm (the reduced NADH
absorption maximum), and at 410 nm. NADH concentra-
tion was estimated using an extinction coefﬁcient of
6.22 mM)1Æcm )1.
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Kinetic parameters were determined by the program
GRAPHPAD PRISM (http://www.graphpad.com).
Single turnover assay
Single turnover assays of the individual components
(10 nmol of Tomo H, 20 nmol of Tomo C and Tomo D
subunits) and of each of their possible combinations, were
performed by adding the proteins to reaction mixtures
containing 0.1 M Tris/HCl, pH 7.5, and 1 mM p-cresol, in a
ﬁnal volume of 200 lL. Anaerobiosis was established by
repeated cycles of ﬂushing and ﬁlling with nitrogen. Fully
reduced proteins were obtained by the addition of sodium
dithionite in a 10-fold molar excess relative to the concen-
tration of Tomo A, in the presence of 50 lM methyl
viologen as a redox mediator. Reactions were started by air
injection and vigorousmixing, and then incubated for 3 min
at 25 C. To measure the amount of 4-MC obtained from
p-cresol oxidation, each sample was ﬁrst diluted twofold
with 200 lL of water, and used to record the baseline.
Saturating amounts of catechol 2,3-dioxygenase were
then added, and the spectrum recorded after 5 min of
incubation. The total amount of hydroxymuconic semial-
dehyde was calculated by its absorption at 382 nm
(e ¼ 28 100 M)1Æcm)1), after baseline subtraction.
Protein sequencing and mass spectrometry
Protein sequencing, electrospray mass spectrometric meas-
urements, and MALDI mass spectrometry (MALDI/MS)
analysis of peptide mixtures was performed as already
described [13].
Iron and labile sulfide determination
Total iron content was determined colorimetrically by
complexation with Ferene S [10], or Ferrozine [21].
Inorganic sulﬁde content was determined by methylene
blue formation as described by Rabinowitz [22] and
Brumby [23], with a minor modiﬁcation of the incubation
time with the alkaline zinc reagent, which was extended to
2 h.
Extraction and identification of FAD from TomoF
Flavin content of Tomo F was calculated spectrophoto-
metrically after heat denaturation of the protein. Enzyme
solutions were kept in boiling water for 3 min, the resulting
precipitate was removed by centrifugation, and the spec-
trum of the supernatant recorded. Flavin cofactor concen-
tration was estimated using an extinction coefﬁcient of
11.3 mM)1Æcm)1, at 450 nm.
Flavin identity was conﬁrmed by reverse phase HPLC
of the supernatant on a C18–silica column. The sample
was loaded on the column equilibrated in 2% acetonitrile
in water containing 0.1% (v/v) triﬂuoroacetic acid, and
washed for 10 min in the same solvent. Elution was
carried out using an isocratic elution with 8% (v/v)
acetonitrile in water containing 0.1% (v/v) triﬂuoroacetic
acid. The identiﬁcation of the ﬂavin cofactor was
obtained by comparing the retention time of the eluted
peak with that of reference samples of authentic FAD
and FMN.
Tomo C reduction by sodium dithionite
Reduction of Tomo C was obtained by the anaerobic
addition of a 100-fold excess of sodium dithionite with
respect to the protein. Sodium dithionite was prepared as a
100-mM solution in 25 mM Mops, pH 6.9.
Separation of the subunits of the subcomplex H
Subunits B, E and A from Tomo H were separated by
HPLC using a Phenomenex Jupiter narrow bore C4 column
(2.1 · 250 mm, 300 A˚ pore size), at a ﬂow rate of
0.2 mLÆmin)1 with a linear gradient of a two-solvent
system. Solvent A was 0.1% (v/v) triﬂuoroacetic acid in
water, solvent B was acetonitrile containing 0.07% (v/v)
triﬂuoroacetic acid. Proteins were separated by a multistep
gradient of solvent B from 10–40% in 40 min followed by
10 min isocratic elution, from 40–50% in 40 min.
Estimation of molecular mass by gel filtration
Determination of the molecular mass was performed by gel
ﬁltration on a Superose 12 PC 3.2/30 (3.2 mm · 300 mm)
column equilibrated in 25 mM Mops, pH 6.9, containing
0.2 M NaCl, using a SMART-System (Pharmacia Biotech).
The molecular mass markers used as standards for gel
ﬁltration chromatography were b-amylase (200 kDa),
aspartate aminotransferase (90 kDa), ribosome inactivating
protein (29 kDa) and onconase (11.8 kDa).
Other methods
SDS/PAGE was carried out according to Laemmli [24].
Protein concentrations were determined colorimetrically
with the Bradford Reagent [25] from Sigma, using 1–10 lg
BSA as a standard. N-terminal protein sequence determi-
nations were performed on an Applied Biosystems seque-
nator (model 473A), connected online with an HPLC
apparatus for identiﬁcation of phenylthiohydantoin deri-
vatives. Amino-terminal sequencing was carried out on
polypeptides separated by denaturing gel electrophoresis
and then electroblotted onto PVDF membranes [17].
R E S U L T S A N D D I S C U S S I O N
Characterization of recombinant Tomo C
When recombinant Tomo C was analyzed by electrospray
mass spectrometry, the protein was found to possess a
molecular mass of 12 372.7 ± 0.9 Da, consistent with that
ofmature TomoCwith six free sulfydryls, whose theoretical
molecular mass is 12 372.8 Da, as calculated on the basis of
the amino acid sequence deduced by the nucleotide
sequence.
The primary structure of recombinant Tomo C was
veriﬁed by peptide mapping. Aliquots of the HPLC puriﬁed
protein were digested with trypsin and the resulting peptide
mixtures were analyzed by MALDI/MS. The mass signals
recorded in the spectra were mapped onto the anticipated
sequence of subunit C on the basis of their mass value and
the speciﬁcity of the enzyme, leading to the complete
veriﬁcation of the amino acid sequence of subunit C
(GenBank accession number AJ005663).
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Tomo C solutions, colored in brown-orange, showed an
absorbance spectrumwith fourmaxima at 278, 323, 458 and
560 nm (Fig. 2A) consistent with the presence of a Rieske-
type [2Fe)2S] center. Among several preparations of
puriﬁed Tomo C, the ratio of A458 : A278 was always found
to be higher than 0.21, in agreement with the data reported
for T4MOC [26] and for the Rieske iron–sulfur protein
from Thermus thermophilus [19]. The inset of Fig. 2A shows
also the spectrum of the reduced form of Tomo C, obtained
by reduction with sodium dithionite. The absorbance at
458 nm decreased by about 50%, whereas two newmaxima
appeared at 420 nm and 520 nm. Tomo C was found to be
reversibly reoxidized in the presence of air (Fig. 2A, inset).
The spectrum of the oxidized form of Tomo C did not
change in presence of stoichiometric amounts of Tomo D
andTomoHor substoichiometric amounts of TomoF. The
effect on Tomo C of equimolar amounts of Tomo F could
not be investigated because this subunit absorbs in the same
spectral region of Tomo C.
Iron content was determined to be 1.6–1.8 molÆmol)1 of
protein, while acid-labile sulﬁde content was found to be
1.8–2.1 molÆmol)1 of protein. Thus, we can conﬁdently
conclude that recombinant Tomo C contains one Rieske-
type [2Fe)2S] center per enzyme molecule.
Characterization of recombinant Tomo F
Samples of puriﬁed subunit F were subjected to electrospray
mass spectrometry. The average molecular mass value
measured for Tomo F was 38 044.03 ± 1.6 Da. This value
is in good agreement with the theoretical value calculated on
the basis of the deduced amino acid sequence of subunit F
lacking the initial methionine residue (38 043.5 Da).
The primary structure of the recombinant subunit F of
Tomo was veriﬁed by the same strategy used for Tomo C.
The protein is 9 residues longer than the sequence
predicted on the basis of the translation of the touF gene
(GenBank accession number AJ005663), thus conﬁrming
the corrections we have inserted in that sequence and
reported in GenBank at accession number AJ438269.
The UV/VIS spectrum of puriﬁed Tomo F (curve 1 of
Fig. 2B) shows absorbance maxima around 273, 335, 385
and 454 nm, with shoulders at 425 and 480 nm as already
reported for other oxidoreductases from several complexes
[10,18,27–29]. Moreover, A273 : A454 ratios determined over
several Tomo F preparations ranged from 3.5 to 3.9, in
agreement with data collected for phthalate oxygenase
reductase from Pseudomonas cepacia and for phenol
hydroxylase from Acinetobacter radioresistens [21,30].
When the enzyme solution was heated to 100 C, the
spectrum recorded for the soluble fraction was that of free
FAD, as shown in Fig. 2B (curve 2). This was conﬁrmed by
HPLC analysis carried out as described in Materials and
methods. Quantitative analysis of bound FAD yielded the
value of 1.1–1.2 mol of FAD per mole of protein.
The iron content of Tomo F was 1.8–2.1 molÆmol)1 of
protein, and the acid-labile sulﬁde content was found to be
between 2 and 2.3 molÆmol)1 of protein.
Therefore we can conﬁdently conclude that Tomo F
contains one [2Fe)2S] center and one FAD molecule.
The speciﬁc activity of Tomo F measured using Tomo C
subunit as a speciﬁc acceptor was found to be
73.6 ± 2.3 UÆmg)1. It should be noted that the activity of
the protein is strictly dependent on the presence of the iron
center. In fact, when apo-Tomo F (which contains FAD)
was used as a catalyst in the same assay, no activity was
detected. This indicates that the lack of the [2Fe)2S] cluster
prevents electron transfer from NADH to the acceptor,
which conﬁrms the role of the iron sulfur cluster as the
redox mediator between FAD and the iron center. The lack
of the cluster in apo-Tomo F was conﬁrmed also by the
spectrum of the protein (Fig. 2B, curve 3), which is that
typical of a ﬂavoprotein with maxima at 273, 390 and
450 nm, and a shoulder at 480 nm [29].
Furthermore, the speciﬁc activity of a different type of
recombinant Tomo F, expressed in a soluble form using
pBZ1260 expression vector [3] was also measured, and
found to be about 50 UÆmg)1. This value is almost identical
Fig. 2. Absorption spectra of (A) puriﬁed oxidized and reduced Tomo C
and (B) recombinant Tomo F. (A) Absorption spectrum of puriﬁed
oxidized TomoC (23 lM) in buﬀer A containing 0.3 MNaCl. The inset
shows the spectra of sodium dithionite reduced (23 lM), and air
reoxidized TomoC. (B) Absorption spectrum of: curve 1, recombinant
(0.34 mgÆmL)1) Tomo F; curve 2, ﬂavin nucleotide dissociated from
recombinant Tomo F after heat denaturation as described in the text;
curve 3, apo-Tomo F (0.45 mgÆmL)1). Samples were all dissolved in
50 mM Tris/HCl, pH 7.0, containing 5% (v/v) glycerol and 0.25 M
NaCl.
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to that measured for recombinant Tomo F renatured
in vitro following the procedure described in the present
paper. This result strongly supports the idea that in vitro
renatured Tomo F is functionally identical to naturally
folded Tomo F.
The ability of Tomo F to use either NADH or NADPH
as electron donors was also measured. The speciﬁc activity
with NADPH was 0.718 ± 0.09 UÆmg)1, i.e. about 100-
fold lower than that determined using NADH as electron
donor. These values, while conﬁrming that Tomo F can use
either NADH or NADPH, indicate that the protein is
speciﬁc for NADH, in line with the results obtained with
other oxygenases [27,31,32].
The ability of recombinant Tomo F to transfer electrons
from NADH to Tomo C was also studied, measuring the
effect (a) on the Tomo F spectrum after the addition of
NADH, and (b) on the TomoC spectrum after the addition
of NADH followed by the addition of Tomo F.
When recombinant Tomo F was incubated (Fig. 3, curve
1), with an eightfold excess of NADH, progressive changes
in its spectral properties were observed. The spectra were
recorded up to 15 min. After 1 min (Fig. 3, curve 2) a
decrease in absorbance at 454 nm (about 52% of the initial
value) was recorded, and three new maxima appeared at
534, 583 and 640 nm, with an isosbestic point at 518 nm. As
shown in Fig. 3 curve 3, the spectrum closely resembles
those reported for other reductases in their reduced form
[27,28], in which the increase in absorbance between 520 nm
and 700 nm has been ascribed to FAD reduction [27,28]. At
about 3 min NADH was found to be almost completely
reoxidized, as indicated by the disappearance of the peak at
340 nm. From this time on, a progressive increase of the
absorbance at 454 nm and a concomitant absorption
decrease in the range 520–700 nm was recorded, which
can be ascribed to the reoxidation of Tomo F by oxygen in
solution. After 15 min (Fig. 3, curve 4) the spectrum
became almost that of oxidized Tomo F. This indicates
that the reversible transfer of electrons was complete.
As for the transfer of electrons from recombinant
Tomo F to Tomo C, curve 1 in Fig. 4 shows the spectrum
of Tomo C in which the typical spectrum of the oxidized
form is evident [19,33], with absorbance maxima at 278,
323, 458 and 560 nm. NADH addition did not change the
spectrum (Fig. 4, curve 2), which indicates the inability of
Tomo C to accept electrons directly from NADH.
Addition of recombinant Tomo F to the mixture induces
a decrease in the absorbance between 400 and 600 nm,
with a shift of the peaks at 458 and 560 nm to 420 and
520 nm, respectively, characteristic of the reduced form of
Tomo C [19,33].
The maximum decrease in absorbance was monitored
after 1 min (Fig. 4, curve 3). After 7 min (Fig. 4, curve 4)
the disappearance of the peak at 340 nm was observed, due
to the complete NADH oxidation, with the gradual shift of
the peaks at 420 and 520 nm to 458 and 560 nm,
respectively, thus indicating the reoxidation of Tomo C.
After 11 min (Fig. 4, curve 5) the typical spectrum of
oxidized Tomo C was recorded, due to the transfer of
electrons to oxygen.
These data give a direct evidence of the direction of the
electron transfer from Tomo F to Tomo C.
Characterization of Tomo H subcomplex
Expression, puriﬁcation and quaternary structure studies.
A comparison of the deduced amino acid sequences of
the six ORFs of the tou gene cluster from P. stutzeri
OX1 with the counterparts found in databases led us to
assign a putative function to each component of the
multicomponent monooxygenase system [3,4]. These
studies led to the hypothesis that subunits B, E and A
might constitute a subcomplex, endowed with hydroxy-
lase activity, as occurs in other monooxygenase com-
plexes [7,9,10,18,34].
The puriﬁcation procedure of the proteins expressed by
plasmid pET22b(+)/touBEA showed that Tomo B, E and
A coeluted in a single peak in all the chromatographic
systems. As these included ion-exchange and gel ﬁltration
chromatography, and the proteins were expected to have
different isoelectric points and different molecular masses
(10, 38 and 57 kDa, respectively), these results suggest the
association of the polypeptides in a complex.
The protein mixture derived from the last gel ﬁltration
step of the puriﬁcation procedure was then subjected to
molecular mass determination by gel ﬁltration on a
Superose 12 PC 3.2/30. The apparent molecular mass was
found to be 206 kDa. This value is consistent with the
hypothesis that the three proteins associate to form a stable
complex, named Tomo H, whose quaternary structure is
(BEA)2, similar to other hydroxylase complexes of mono-
oxygenases [18,33,34].
Samples of puriﬁed Tomo H subcomplex were analyzed
by LC/MS. Components B, E and A showed molecular
mass of 9841.6 ± 0.6 Da, 38 201.4 ± 2.9 Da and
57 591.5 ± 3.6 Da, respectively. These values are in good
agreement with the expected molecular mass calculated on
the basis of the deduced amino acid sequence of the mature
Fig. 3. Reduction of recombinant Tomo F by NADH. Spectra were
recorded at the times indicated below upon the addition of NADH
(ﬁnal concentration 37.4 lM) to a solution of recombinant Tomo F
(4.7 lM) dissolved in 50 mM Tris/HCl, pH 7.0, containing 5% (v/v)
glycerol and 0.25 M NaCl. Curve 1, spectrum of oxidized Tomo F
before addition of NADH; curve 2, 1 min; curve 3, 3 min; curve 4,
15 min. Curves not labeled with numbers have been recorded between
3 and 15 min after NADH addition.
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form of the subunits (B, 9842.2 Da; E, 38 202.9 Da and A,
57 593.7 Da).
The primary structure of the recombinant subunits of
Tomo H subcomplex was veriﬁed by peptide mapping as
described for subunit C. The results led to the complete
veriﬁcation of the amino acid sequence of subunits B, E
and A, demonstrating that the subunits of the recombi-
nant complex Tomo H have the amino acid sequence
predicted on the basis of the corresponding DNA
sequences, as present in the GenBank at the accession
number AJ005663.
Finally, the iron content of the complex was determined
and found to be 3.4 molÆmol)1 of Tomo H. This result is in
agreement with the presence of a diiron center in each of the
subunit Tomo A, as suggested by its homology with other
monooxygenases large subunit [33–35].
Moreover, the absorption spectrum of puriﬁed recom-
binant Tomo H is featureless above 300 nm. The lack of
absorption in the visible region suggests that Tomo H has a
hydroxo-bridged diiron center similar to that described
for methane monooxygenase hydroxylase complex from
Methylococcus capsulatus [34], alkene monooxygenase from
Nocardia corallina B-276 [12] and for T4MO [33], rather
than an oxo-bridged diiron center [36].
Reconstitution of the Tomo complex from recombinant
subunits
Functional characterization of the recombinant subunits of
the complex of toluene/o-xylene monooxygenase was car-
ried by testing their ability to reconstitute a functional
complex, i.e. the ability to catalyze the conversion of a
substrate into a product, mediated by electrons coming
from the donor NADH.
Preliminary multiple-turnover activity assays indicated
that mixtures of equimolar amounts of the puriﬁed Tomo
components were able to transform p-cresol into 4-MC.
To determine the optimal relative concentration of each
subunit in order to obtain maximum hydroxylase activity
we carried out kinetic measurements using mixtures of
Tomo H, F, C and D, and changing the concentration of
each single component.
Figure 5 shows the effects on the rate of reaction of
increasing ratios of Tomo F, Tomo C and Tomo D with
respect to Tomo H in the presence of constant amounts of
the other components. A linear relationship is obtained at
low ratios of Tomo C and D followed by a sharp break at
about 1.6 mol of Tomo C per mol of TomoH and 3 mol of
Tomo D per mol of Tomo H (Fig. 5A,B), respectively. The
nearly linear titration and the break is an indication of a
high afﬁnity of these components for Tomo H as already
observed for the regulatory component of methane mono-
oxygenase (MMO) [37], and suggests the existence of a
stable complex between Tomo H, Tomo C and Tomo D
with a possible stoichiometry of 1 : 2 : 2 (relative to Tomo
H).
Tomo F instead shows a different behavior. In fact, the
maximum velocity is reached at substoichiometric amounts
of this component with respect to Tomo H (about 0.2 mol
of Tomo F per mol of Tomo H), and no titration break is
present (Fig. 5C). These results would suggest that TomoF,
unlike Tomo C and D, does not form a stable complex with
Tomo H, as observed for the reductase component of
MMO [37].
Based on the information above, we measured the kinetic
parameters of the reconstituted complex using saturating
ratios of the components. The value of the speciﬁc activity
was 380 ± 30 nmol of p-cresol converted permin permg of
Fig. 4. Reduction of Tomo C by recombinant
Tomo F and NADH. Curve 1, spectrum of a
solution (23.5 lM) of Tomo C in 25 mM
Mops, pH 6.9, containing 1% (v/v) glycerol,
2% (v/v) ethanol and 0.06 M NaCl. Curve 2
(bold line), same as curve 1, upon addition of
NADH (ﬁnal concentration 23.5 lM). Curve
3, same as curve 2 immediately after addition
of 0.32 lg of recombinant Tomo F (16.7 nM).
Spectra recorded after 7 min (curve 4) and
11 min (curve 5) after recombinant Tomo F
addition are also shown.
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Tomo H, whereas kcat and Km values were 0.62 ± 0.02 s
)1
and 13.3 ± 1.3 lM, respectively. It should be noted that the
Km value is in good agreement with that determined using
E. coli cells expressing the entire Tomo complex from vector
pBZ1260 (19.4 ± 2 lM).
Thus, we can conﬁdently conclude that the recombinant
components expressed and puriﬁed with the procedures
described above are able to reconstitute an active Tomo
complex in which all the individual subunits are functional.
To identify the hydroxylase component of the complex
we performed single-turnover assays, in the absence of the
Tomo F subunit, by measuring the ability of Tomo H,
Tomo C and Tomo D, in each possible combination, to
oxidize p-cresol to 4-MC.
The results of the experiments carried out as described in
Materials and methods, using sodium dithionite as a
reductant and methyl viologen as a redox mediator, are
reported in Table 1. They clearly indicate that only TomoH
by itself is able to convert p-cresol, thus strongly supporting
its identiﬁcation with the hydroxylase component of the
complex, in agreement with the hypothesis based on
homology studies [4].
Data of Table 1 also indicate that addition of Tomo C or
TomoD to TomoH increases the amount of the product of
2.3- and 3.6-fold, respectively, with respect to that measured
in their absence. Moreover, when all the three components
were present, a 23-fold increase in the amount of the
product, with respect to that produced in the presence of
Tomo H alone, was recorded. This latter data is clear
evidence of a cooperative interaction between the three
components, suggestive of the formation of a ternary
complex, as it has been demonstrated for other homologous
monooxygenases [37,38].
As for the increase in the amount of 4-MC produced in
the presence of both Tomo H and Tomo C, it may well be
attributed to the ability of reduced Tomo C to transfer
additional electrons to Tomo H, thus promoting more than
one reaction cycle in the single turnover assay. This data,
together with the observation that TomoC can be reversibly
reduced in the presence of Tomo F and NADH, strongly
support the idea that Tomo C acts as a mediator in the
electron transfer chain between Tomo F and Tomo H, in
line with the hypothesis raised on the basis of homology
studies [4].
As for TomoD, a protein devoid of any redox center [13],
the data of Table 1 support (although not conclusively) its
regulatory role in the complex. In fact, the 3.6-fold increase
in the ability of TomoH to transform p-cresol into 4-MC, in
the absence of any capability of Tomo D to transfer
electrons, can be attributed to its capacity to modulate the
activity of the hydroxylase component of the complex, as it
Table 1. Single-turnover assays catalyzed by the components of the
toluene/o-xylene monooxygenase complex. The experiments were per-
formed as described inMaterials and methods using 10 nmol of Tomo
H and 20 nmol of Tomo C and Tomo D.




Tomo H + Tomo C 0.173
Tomo H + Tomo D 0.271
Tomo H + Tomo C + Tomo D 1.72
Fig. 5. The eﬀect of diﬀerent ratios of Tomo C (A), Tomo D (B) and
Tomo F (C) components with respect to the hydroxylase on the rate of
toluene/o-xylene monooxygenase. Activity was measured as described
in Materials and methods. Curve A: Tomo H, 0.15 lM; Tomo D,
0.75 lM; Tomo F, 0.075 lM. Curve B: Tomo H, 0.15 lM; Tomo C,
0.75 lM; TomoF, 0.075 lM. Curve C: TomoH, 0.15 lM; TomoC and
D, 0.75 lM.
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has already been demonstrated for homologous proteins
such as T4MOD of the T4MO from P. mendocinaKR1 [33]
and subunit B of methane monooxygenases [38,39].
Moreover, it should be noted that the omission of
Tomo D in multiple-turnover assays leads to a complete
absence of activity (data not shown) despite the presence
of all the other components of the electron transport
chain. This result is in line with the absence of any
oxidase activity recorded in experiments carried out in vivo
on E. coli cells harboring a cluster tou in which touD gene
was inactivated by partial deletion [4]. However, it should
be noted that this data does not parallel the effect of the
absence of other homologous regulatory subunits of
oxygenase complexes, like T4MOD [33] and component
B of methane monooxygenases [38,39]. In these cases the
absence of the regulatory subunit induces only a reduction
of the hydroxylase activity.
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